Search For

Serum TUBB is a potential biomarker for the diagnosis of non-small cell lung cancer

ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy

Editorial on “Chinese expert consensus on the clinical practice of non-small cell lung cancer fusion gene detection based on RNA-based NGS” (2023 edition)

ZNF148/PFKP/PD-L1 axis promotes non-small cell lung cancer proliferation, migration and glycolysis

Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances

Early detection of non-small cell lung cancer in liquid biopsies by ultrasensitive protease activity analysis

RANBP9 as potential therapeutic target in non-small cell lung cancer

PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer

Radiotherapy of brain metastases from non-small cell lung cancer

Impact of previous anti-angiogenesis treatment in nivolumab-treated advanced non-small cell lung cancer

Do elderly NSCLC stage IV patients benefit from chemotherapy as well as younger? An analysis from clinical practice date

Changing paradigm in treatment of lung cancer